ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,650Medicare Part D Prescriptions Filled, Including Refills

Rank: 122 out of 617

$569K Total Retail Price of All Prescriptions

Rank: 60 out of 617

374 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 374 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 374 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,578 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 505 477 1 1
OMEPRAZOLE 346 277 2 3
SIMVASTATIN 305 263 3 2
WARFARIN SODIUM 282 262 4 7
AMLODIPINE BESYLATE 266 243 5 6
METFORMIN HCL 239 207 6 9
FUROSEMIDE 238 216 7 4
HYDROCHLOROTHIAZIDE 192 181 8 13
METOPROLOL TARTRATE 190 183 9 11
METOPROLOL SUCCINATE 184 183 10 12
LISINOPRIL 182 176 11 5
NAMENDA 173 173 12 35
POTASSIUM CHLORIDE 172 160 13 10
ATORVASTATIN CALCIUM 163 152 14 14
HYDROCODONE-ACETAMINOPHEN 148 128 S3 15 8
LOSARTAN POTASSIUM 139 139 16 22
FENTANYL 139 136 S2 16 45
ATENOLOL 126 121 18 17
SERTRALINE HCL 117 88 19 20
SYNTHROID 114 72 20 59
CEPHALEXIN 105 101 21 68
ENALAPRIL MALEATE 92 72 22 34
LANTUS 88 68 23 39
TAMSULOSIN HCL 88 84 23 26
GABAPENTIN 86 86 25 16
POLYETHYLENE GLYCOL 3350 84 84 26 32
CARBIDOPA-LEVODOPA 83 83 27 69
PAROXETINE HCL 83 83 27 62
SPIRIVA 74 73 29 61
DIGOXIN 74 74 29 48
RISPERIDONE 72 72 31 71
ZOLPIDEM TARTRATE 72 60 31 23
LIPITOR 71 66 33 118
SYMBICORT 68 50 34 141
RANITIDINE HCL 64 62 35 40
MIRTAZAPINE 64 64 35 50
JANUVIA 60 37 37 107
CARVEDILOL 60 51 37 19
CRESTOR 59 56 39 28
CYMBALTA 56 34 40 49
ROPINIROLE HCL 56 47 40 66
DONEPEZIL HCL 55 55 42 30
CIPROFLOXACIN HCL 55 54 42 60
LEVOTHROID 54 54 44 172
PREDNISONE 54 48 44 31
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 50 46 91
AZITHROMYCIN 51 46 47 70
EXELON 51 51 47 156
CLOPIDOGREL 50 49 49 53
BYSTOLIC 50 50 49 64
SPIRONOLACTONE 50 46 49 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.